Candida auris has emerged as a major pathogen of concern in acute care and intensive care units (ICUs) worldwide. Unlike traditional yeast strains, C. auris persists on environmental surfaces for extended periods and resists standard quaternary ammonium disinfectants.
To prevent nosocomial transmission in Canadian hospitals and surgical suites, environmental service teams must deploy Health Canada DIN-registered sporicidal chemistries, such as hydrogen peroxide vapors or sodium dichloroisocyanurate (NaDCC) solutions, coupled with quantitative ATP bio-burden testing.
Dr. Marc Tremblay, Epidemiologist is a senior healthcare environmental consultant specializing in IPAC Canada compliance, bio-burden reduction, and chemical safety for Canadian healthcare institutions.
